New Clinical Trial Awarded to Study Geographic Atrophy in Age-Related Macular Degeneration

The WashU Medicine John F. Hardesty, MD Department of Ophthalmology & Visual Sciences has received a notice of award for a new clinical trial focused on advancing treatment options for patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD). The study, titled “Efficacy of Dapagliflozin in Geographic Atrophy Secondary to Age-Related Macular Degeneration: […]

Congrats, Matt Elitt, MD, PhD!

Matt Elitt and Paul Tesar

Congratulations to WashU Ophthalmology Resident, Matt Elitt, MD, PhD and Case Western Reserve’s Tesar Lab colleagues, on the advancement of ION356 to a phase I human clinical trial. Dr. Elitt’s doctoral research published in Nature demonstrated a novel method to pharmacologically target the pathology of Pelizaeus-Merzbacher disease (PMD), representing the first potential treatment option for patients and […]